Key Takeaways
- • Blackstone has closed Blackstone Life Sciences VI (BXLS VI) at a hard cap of $6.3 billion, which the firm describes as the largest private fund ever dedicated to the life sciences sector.
- • The fund reportedly closed oversubscribed at its hard cap, according to coverage cited in the sources, with a March 30, 2026 closing date referenced.
- • The fund is classified as a buyout vehicle, per a fund profile in the sources.
- • The same Mingtiandi roundup also covered Singapore's largest government land tender of the year at Bayshore, a mixed-use site, which was reported alongside the Blackstone close.
Summary
Blackstone has closed its latest life sciences fund, Blackstone Life Sciences VI (BXLS VI), at a hard cap of $6.3 billion, according to the firm and multiple reports cited in the source material. The firm says the vehicle is the largest private fund ever raised for the life sciences sector. Coverage describes the fund as closing oversubscribed at its hard cap, and a March 30, 2026 closing date is referenced in the sources.
A fund profile in the source material classifies BXLS VI as a buyout fund. Commercial Observer reported the close as marking the largest private life sciences fund ever raised.
The Mingtiandi roundup in which the story appeared also covered Singapore's launch of its largest government land tender of the year, at Bayshore, a mixed-use site. Full text of the original Mingtiandi article could not be retrieved, so the details above are drawn from headlines, snippets and secondary references.
A fund profile in the source material classifies BXLS VI as a buyout fund. Commercial Observer reported the close as marking the largest private life sciences fund ever raised.
The Mingtiandi roundup in which the story appeared also covered Singapore's launch of its largest government land tender of the year, at Bayshore, a mixed-use site. Full text of the original Mingtiandi article could not be retrieved, so the details above are drawn from headlines, snippets and secondary references.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.